RSV Vaccine
GSK’s Arexvy Vaccine Poised for Blockbuster Sales, Besting Pfizer in RSV Market Debut
Pfizer is facing not only a decline in its COVID-19 vaccine sales but also stiff competition from GSK in the ...
GSKās RSV vaccine poised for label expansion after trial success
Five months after GSK made history by securing FDA approval for its respiratory syncytial virus (RSV) vaccine, Arexvy, the company ...
Pfizer’s Abrysvo Secures CDC Endorsement for Infant Protection, Intensifying RSV Vaccine Competition
Despite GSKās Arexvy pioneering the respiratory syncytial virus (RSV) vaccine landscape earlier this summer, Pfizer has persistently challenged the competition ...
Modernaās mRNA flu vaccine shows phase 3 success, plans for combo shots by 2025
Moderna has achieved significant progress in its quest to develop an mRNA flu vaccine, with the updated mRNA-1010 version successfully ...
GSK boosts vaccine production with ā¬250M facility for shingles, RSV and malaria shots
As GlaxoSmithKline (GSK) continues to expand its vaccine portfolio with the introduction of the new respiratory syncytial virus (RSV) vaccine, ...
Moderna finds promise in the private COVID vaccination market and the debut of RSV as sales plummet
Source – Fiercepharma As Moderna continues its operations beyond the pandemic, the biotech firm has increased its revenue projection for ...
Moderna Submits Global Regulatory Applications for its RSV Vaccine, mRNA-1345
Source – Moderna On July 5, 2023 Moderna, a biotech company at the forefront of mRNA vaccines, shared an update ...
CDC advisory group reviews GSK and Pfizer RSV vaccinations
Source – Fierce Pharma On June 21, 2023, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease ...
Pfizerās RSV Vaccine ABRYSVO: A Breakthrough for the Industry and RSV Prevention
Pfizerās RSV Vaccine: In a groundbreaking development, Pfizer’s FDA approval for its RSV vaccine, ABRYSVO, has not only positioned the ...
